Corrigendum: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers (Nature Medicine, (2012), 18, 1, (74-82), 10.1038/nm.2577)

Michela Garofalo, Giulia Romano, Gianpiero Di Leva, Gerard Nuovo, Young Jun Jeon, Apollinaire Ngankeu, Jin Sun, Francesca Lovat, Hansjuerg Alder, Gerolama Condorelli, Jeffrey A. Engelman, Mayumi Ono, Jin Kyung Rho, Luciano Cascione, Stefano Volinia, Kenneth P. Nephew, Carlo M. Croce

Research output: Contribution to journalComment/debate

Abstract

In the version of this article initially published, the actin loading control of the western blot in Figure 1a was a rotated duplicate of the actin control in Figure 1h. The authors have not been able to provide the original control data, but they have repeated the experiment and have provided new blots (Fig. 1) that are now published as part of the correction notices linked to the HTML version and attached to the PDF version of the article. The original blots remain in both online versions of the article. In addition, Figure 6g contained a spliced gel that has now been corrected in the HTML and PDF versions of the article.

Original languageEnglish (US)
Number of pages1
JournalNature Medicine
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Corrigendum: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers (Nature Medicine, (2012), 18, 1, (74-82), 10.1038/nm.2577)'. Together they form a unique fingerprint.

  • Cite this

    Garofalo, M., Romano, G., Di Leva, G., Nuovo, G., Jeon, Y. J., Ngankeu, A., Sun, J., Lovat, F., Alder, H., Condorelli, G., Engelman, J. A., Ono, M., Rho, J. K., Cascione, L., Volinia, S., Nephew, K. P., & Croce, C. M. (2014). Corrigendum: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers (Nature Medicine, (2012), 18, 1, (74-82), 10.1038/nm.2577). Nature Medicine, 20(1). https://doi.org/10.1038/nm0114-103